Yusupov, Natan
Roeh, Simone
Sotillos Elliott, Laura
Chang, Simon http://orcid.org/0000-0002-7276-0629
Loganathan, Srivaishnavi
Urbina-Treviño, Lidia
Fröhlich, Anna S. http://orcid.org/0000-0001-5911-924X
Sauer, Susann
Ködel, Maik
Matosin, Natalie
Czamara, Darina http://orcid.org/0000-0001-7381-904X
Deussing, Jan M. http://orcid.org/0000-0002-9329-5252
Binder, Elisabeth B. http://orcid.org/0000-0001-7088-6618
Funding for this research was provided by:
Hope for Depression Research Foundation
Else-Kroener-Fresenius Foundation
Alexander von Humboldt-Stiftung
Article History
Received: 20 July 2023
Revised: 19 December 2023
Accepted: 11 January 2024
First Online: 5 February 2024
Competing interests
: EBB is co-inventor on a EU patent application, EP1687443B1, Fkbp51: a novel target for antidepressant therapy. All other authors have no conflicts of interest to declare that are relevant to the content of this article.